OpenAI offers US university labs free GPT-Rosalind access for up to 12 months

EdTech Innovation Hub

Source published: Site published:

Original article · فارسی

The new academic plan offers up to 30 sponsored seats for each eligible lab. Access to the specialized life sciences model requires approval.

Illustrative image accompanying ETIH coverage of OpenAI's Rosalind Academic Plan, which provides US university laboratories with access to AI tools developed to support scientific and life sciences research.

OpenAI's Rosalind Academic Plan gives eligible research labs at US universities up to 12 months of sponsored access to AI tools. Access to GPT-Rosalind requires approval.

OpenAI has launched the Rosalind Academic Plan. It gives eligible research labs at US universities up to 12 months of free access to its AI tools. These include the option to use GPT-Rosalind, a special AI model made to support research in the life sciences.

The plan gives each lab up to 30 Business Standard seats at no cost. Labs must get separate approval through a trusted-access process to use GPT-Rosalind. Researchers can also use OpenAI's advanced models that are available to paying customers, subject to the plan's usage limits.

The offer is only available to academic labs at US universities. It does not include API access.

GPT-Rosalind combines AI reasoning designed for specialized tasks with Rosalind Workbench. The Workbench helps researchers use scientific tools for tasks such as medicinal chemistry, genomics, work in a lab, and other research activities.

Academic researchers get access to specialized AI tools

OpenAI says university research labs are already testing GPT-Rosalind for tasks ranging from designing proteins to studying neurodegeneration, a process in which nerve cells in the brain and nervous system become damaged or die.

One example is the Zhao Lab at UCSF. The lab has used the model to collect information about drug properties to support quantitative drug development.

"GPT‑Rosalind helped me gather drug physicochemical parameters faster. PubChem and NCBI tools helped me work across ten drugs while refining the distinction between predicted and experimentally measured values," the lab says in an example published by OpenAI.

OpenAI describes the model as a research helper, not a replacement for scientific knowledge and experience. In a post on LinkedIn, the company wrote: "Researchers bring the expertise and judgment to evaluate the evidence and decide which ideas to pursue."

OpenAI says it will not use research data shared through the Rosalind Academic Plan to train its models by default.

Access requires checks and approval from the institution

Principal investigators (PIs), who lead research projects, and lab leaders manage participation. They can apply for their teams and oversee access for up to 30 named members.

How a lab applies depends on its university's existing agreement with OpenAI. Labs at universities without an Enterprise agreement can apply directly through the Rosalind Academic Plan. Labs at universities that already have an agreement must request access through their institution's Enterprise account.

Before giving access, OpenAI checks the university and lab leader, reviews the applicant's professional background and research activities, and sets out the responsibilities of both the lab leader and a named institutional safety contact.

OpenAI says it continues to apply safety checks after access begins. These include monitoring and enforcing its rules, with extra attention to approved research settings for registered uses that involve higher sensitivity.

Eligible principal investigators and lab leaders can now apply through the Rosalind Academic Plan. Access to GPT-Rosalind starts after approval. The announcement does not give an application deadline.